Palo Alto Investors LP Q4 2024 Filing
Filed February 14, 2025
Portfolio Value
$645.4M
Holdings
43
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (43 positions)
| Stock | Value |
|---|---|
IM8NINSMED INC | $110.7M |
AM6AMICUS THERAPEUTICS INC | $72.2M |
BMRNBIOMARIN PHARMACEUTICAL INC | $70.2M |
UTHUNITED THERAPEUTICS CORP | $54.9M |
ACADACADIA PHARMACEUTICALS INC | $50.4M |
ALNYALNYLAM PHARMACEUTICALS INC | $33.1M |
BIIBBIOGEN INC | $29.1M |
SRPTSAREPTA THERAPEUTICS INC | $25.6M |
NVCRNOVOCURE LTD | $24.3M |
PRTAPROTHENA CORP PLC | $24.1M |
IOVAIOVANCE BIOTHERAPEUTICS INC | $22.5M |
EHTHEHEALTH INC | $17.7M |
PTCTPTC THERAPEUTICS INC | $17.4M |
STAASTAAR SURGICAL CO | $12.2M |
ANABANAPTYSBIO INC | $11.2M |
ALKSALKERMES PLC | $8.3M |
AFWALIGN TECHNOLOGY INC | $7.9M |
GOSSGOSSAMER BIO INC | $5.7M |
SLRNACELYRIN INC | $5.6M |
SNDXSYNDAX PHARMACEUTICALS INC | $5.4M |
BCYCBICYCLE THERAPEUTICS PLC-ADR | $3.5M |
KPTIEURKARYOPHARM THERAPEUTICS INC | $3.3M |
VERVVERVE THERAPEUTICS INC | $3.2M |
EWEDWARDS LIFESCIENCES CORP | $2.9M |
BNTXBIONTECH SE-ADR | $2.9M |
NVROEURNEVRO CORP | $2.8M |
MIRMMIRUM PHARMACEUTICALS INC | $2.7M |
NUVBNUVATION BIO INC | $2.1M |
TVTXTRAVERE THERAPEUTICS INC | $1.9M |
PYXSPYXIS ONCOLOGY INC | $1.6M |
VYNEVYNE THERAPEUTICS INC PIPE | $1.5M |
ACRSACLARIS THERAPEUTICS INC | $1.4M |
TSHATAYSHA GENE THERAPIES INC | $1.4M |
STOKSTOKE THERAPEUTICS INC | $1.4M |
ALDXALDEYRA THERAPEUTICS INC | $1.1M |
HUMHUMANA INC | $1.0M |
JSPRJASPER THERAPEUTICS INC | $655K |
ABEOABEONA THERAPEUTICS INC | $606K |
URGNUROGEN PHARMA LTD | $261K |
RLMDRELMADA THERAPEUTICS INC | $257K |
TILINSTIL BIO INC | $213K |
AKTXAKARI THERAPEUTICS PLC-ADR | $178K |
GBIOGBXGENERATION BIO CO | $160K |